Dear editor,
We read with great interest of the report by Rosen and colleagues [1] about the effect of awake prone positioning (APP) on intubation rate among patients with moderate to severe hypoxemic respiratory failure (HRF) due to COVID-19. They identified a implemented protocol for APP increased duration of prone positioning, but did not reduce the rate of intubation compared to standard care. From our point of view, some details about whether APP could decrease intubation in patients with HRF due to COVID-19 need to be further clarified.
First, in Rosen’s study [1], the patient in standard care group also received a median prone duration of 3.4 h compared with 9.0 h per day in the prone group, which means that the real intervention factor they investigated was whether a prolonged APP could further decrease intubation rate. Therefore, it may be more appropriate to draw a conclusion that prolonged APP did not reduce the rate of intubation in patients with HRF due to COVID-19.
Second, Rosen and colleagues [1] reported a 33% intubation rate in both groups, which is much lower than that reported in two other studies [2, 3] with similar baseline characteristics, degree of respiratory failure but shorter APP duration (41% and 49% in the control group and 40% and 58% in the prone group) compared with their investigation. Based on this data, could we speculate that prolonged APP does decrease the intubation rate?
Third, in Rosen’s study [1], most patients were put on APP when they were supported with noninvasive ventilation, which is a higher level support than high flow nasal canula (HFNC) [4]. This may indicate that they use the APP more like a “rescue” therapy rather than an “adjunctive” therapy in a late stage of ARF, which may get less response to APP and therefore less difference in intubation rate.
In summary, combining this lack of accuracy of comparison of APP and non-APP patients, and the possibly late initiation of APP in the moderate to severe ARF COVID-19 patients, a priori chance of finding a difference in intubation was low and may explain the negative findings for the APP. And further analysis with data from comparison of non-APP populations and prolonged APP group, especially in patients support with HFNC and prolonged APP, is needed for a more settled conclusion.
Acknowledgements
None.
Authors' contributions
HW and HH are responsible for study design and writing. Both authors read and approved the final manuscript.
Funding
None.
Availability of data and materials
Not applicable.
Declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Footnotes
Comment on: Jacob Rosén, Erik von Oelreich, Diddi Fors, Malin Jonsson Fagerlund, Knut Taxbro, Paul Skorup, Ludvig Eby, Francesca Campoccia Jalde, Niclas Johansson, Gustav Bergström, Peter Frykholm, PROFLO Study Group. Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial. Crit Care. 2021, 25:209. (https://doi.org/10.1186/s13054-021-03602-9. Published on: 14 June 2021).
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Rosen J, von Oelreich E, Fors D, Jonsson Fagerlund M, Taxbro K, Skorup P, Eby L, Campoccia Jalde F, Johansson N, Bergstrom G, et al. Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial. Crit Care. 2021;25(1):209. doi: 10.1186/s13054-021-03602-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ferrando C, Mellado-Artigas R, Gea A, Arruti E, Aldecoa C, Adalia R, Ramasco F, Monedero P, Maseda E, Tamayo G, et al. Awake prone positioning does not reduce the risk of intubation in COVID-19 treated with high-flow nasal oxygen therapy: a multicenter, adjusted cohort study. Crit Care. 2020;24(1):597. doi: 10.1186/s13054-020-03314-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Padrao EMH, Valente FS, Besen B, Rahhal H, Mesquita PS, de Alencar JCG, da Costa MGP, Wanderley APB, Emerenciano DL, Bortoleto FM, et al. Awake prone positioning in COVID-19 hypoxemic respiratory failure: exploratory findings in a single-center retrospective cohort study. Acad Emerg Med. 2020;27(12):1249–1259. doi: 10.1111/acem.14160. [DOI] [PubMed] [Google Scholar]
- 4.Ding L, Wang L, Ma W, He H. Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study. Crit Care. 2020;24(1):28. doi: 10.1186/s13054-020-2738-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Not applicable.